| Project/Area Number |
02671016
|
|---|
| Research Category |
Grant-in-Aid for General Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Research Field |
Biological pharmacy
|
|---|
| Research Institution | Nihon University |
|---|
Principal Investigator |
FUKUDA Hideomi Nihon Univ. Coll. of Pharmacy, Professor, 薬学部, 教授 (50080172)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
ITO Yoshihisa Nihon Univ. Coll. of Pharmacy, Assistant Professor, 薬学部, 専任講師 (50151551)
|
|---|
| Project Period (FY) |
1990 – 1991
|
| Project Status |
Completed (Fiscal Year 1991)
|
| Budget Amount *help |
¥1,900,000 (Direct Cost: ¥1,900,000)
Fiscal Year 1991: ¥800,000 (Direct Cost: ¥800,000)
Fiscal Year 1990: ¥1,100,000 (Direct Cost: ¥1,100,000)
|
|---|
| Keywords | GABA_Areceptor / GABA antagonist / SR 95531 / ^<36>Cl^- uptake / ^<35>S-TBPS binding / Phospholipase A_2 / Cultured cerebellar neuronal cells / synaptoneurosome / ピクロトキシン結合部位 / ビククリンメチオダイド / IC_<50>値 / アゴニスト作用 / 受容体結合実験 / ^<36>Clイオンの取込み / 培養神経細胞 / アゴニスト / アンタゴニスト |
|---|
| Research Abstract |
In the present study, experiments were performed to characterize antagonistic activity and binding properties of SR 95531 [2-(3'carbethoxy-2'-propyl)-3-amino-6-Paramethoxy-phenyl-pyidaziniun bromide]. SR 95531 and bicuculline methiodide (BMI) inhibited muscimol-stimulated ^<36>Cl^- uptake into cortical synaptoneurosomes in a concentration-dependent manner. Inhibitory potency of SR 95531 for the muscimlstimlated ^<36>Cl^- uptake was 15 times higher than that of BMI. The IC_<50> value of SR 95531 for muscimol-stimulated ^<36>Cl^- uptake into cortical synaptoneurosomes was in close agreement with the K_D value of low-affinity binding sites of [ ^3H]SR 95531 in the FC. SR 95531 and BMI antagwonized GABA-induced inhibition of [ ^<35>S]TBPS binding in cortical membranes. SR 95531 was more potent than BMI. Pretreatment of the membranes with phospholipase A_2 (PLase A_2) invariably decreased [ ^3H]SR 95531 binding in the cerebral cortex and the cerebellum. On the other hand, preincubation with
… More
PLase A_2 significantly, increased the binding of [ ^3H]GABA in a concentration-dependent manner in cortical membranes. Although lower concentrations of PLase A_2 did not affect the binding of [ ^3H]GABA in the cerebellum, treatment with higher concentrations of PLase A_2 increased the binding in this region. In addition, PLase A_2-induced increase in the binding of [ ^3H]GABA in the cerebral cortex was greater than that in the cerebellum. Specific binding of [ ^3H]SR 95531 was also detected in cultured cerebellar neuronal cells. Pretreatment with PLase A_2 affected [ ^3H]GABA and [ ^3H]SR 95531 binding in the cultured cerebellar neuronal cells as in the case of the cerebellum. These results suggest that SR 95531 exerts GABA antagonistic action through the low-affinity binding site of SR 95531 and that exogenously added PLase A_2 induces the conversion of GABA_A receptors into the agonist preferential conformation by the products of catalytic activity of PLase A_2. In addition, cultured cerebellar neuronal cells may be a useful tool to investigate the long term effects of various drugs on GABA_A receptor complexes in vitro. Less
|
